Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes
Clinical trial NCT05238012 · COMPLETED
Trial details
- NCT number
- NCT05238012
- Sponsor
- Heart Health Research Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-02
- Primary completion
- 2024-04-02
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.